99 related articles for article (PubMed ID: 6026336)
1. The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.
Searl RO; Pernarowski M
Can Med Assoc J; 1967 Jun; 96(23):1513-20. PubMed ID: 6026336
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of marketed antimalarial chloroquine phosphate tablets.
Patel AK; Prajapati BG; Moria RS; Patel CN
J Vector Borne Dis; 2005 Dec; 42(4):147-50. PubMed ID: 16457384
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical equivalence of chloroquine phosphate tablets.
Bamiro OA; Odeniyi MA; Idowu OB; Jaiyeoba KT
Afr J Med Med Sci; 2004 Dec; 33(4):371-5. PubMed ID: 15977447
[TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo biopharmaceutical evaluation of lorazepam commercial tablets].
Giannone I; Musumeci T; Pecora TM; Puglisi G
Clin Ter; 2005; 156(5):197-201. PubMed ID: 16382968
[TBL] [Abstract][Full Text] [Related]
5. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
Babalola CP; Oladimeji FA; Femi-Oyewo MN
Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of three commercial acetaminophen tablets.
Hekimoğlu S; Ayanoğlu-Dülger G; Hincal AA
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):93-6. PubMed ID: 3557735
[TBL] [Abstract][Full Text] [Related]
7. [The biodisposition of paracetamol. I. The kinetics of disintegration of some dosage forms].
Abebe A; Chulia D; Verain A
Pharm Acta Helv; 1991; 66(2):56-9. PubMed ID: 1758894
[TBL] [Abstract][Full Text] [Related]
8. In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria.
Esimone CO; Okoye FB; Onah BU; Nworu CS; Omeje EO
J Vector Borne Dis; 2008 Mar; 45(1):60-5. PubMed ID: 18399319
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the quality of four Mexican drug products containing sodium naproxen.
Hernández-Abad VJ; Castañeda-Hernández G; García-Jiménez S; Marroquín-Segura R; Sánchez-González E
J Clin Pharm Ther; 2008 Jun; 33(3):237-42. PubMed ID: 18452410
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical equivalent studies of some commercially available brands of Loratadine hydrochloride tablets.
Adetunji OA; Adigun NF; Odeniyi MA
Afr J Med Med Sci; 2015 Sep; 44(3):269-76. PubMed ID: 27280240
[TBL] [Abstract][Full Text] [Related]
11. Comparative dissolution rate studies of commercial furosemide tablets.
Gadalla MA; Ismail AA
Pharmazie; 1981 Aug; 36(8):553-6. PubMed ID: 7291288
[TBL] [Abstract][Full Text] [Related]
12. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
[No Abstract] [Full Text] [Related]
13. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
Abdullah MD; Bepary S; Rouf AS
Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
[TBL] [Abstract][Full Text] [Related]
14. [A comparative biopharmaceutical study of brands of ciprofloxacin tablets available on the Colombian market].
Franco-Ospina LA; Matiz-Melo GE; Pájaro-Bolívar IB
Rev Salud Publica (Bogota); 2012 Aug; 14(4):695-709. PubMed ID: 23912521
[TBL] [Abstract][Full Text] [Related]
15. Prediction of in vivo bioavailability of six brands of ciprofloxacin film coated tablets using the concept dissolution efficiency (DE).
Ofoefule SI; Udeogaranya PO; Okonta JM
Boll Chim Farm; 2001; 140(3):187-91. PubMed ID: 11486612
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
[TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
[TBL] [Abstract][Full Text] [Related]
18. Disintegration/dissolution profiles of copies of Fosamax (alendronate).
Epstein S; Cryer B; Ragi S; Zanchetta JR; Walliser J; Chow J; Johnson MA; Leyes AE
Curr Med Res Opin; 2003; 19(8):781-9. PubMed ID: 14687450
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
Sylvestri MF; Ueda CT
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
[TBL] [Abstract][Full Text] [Related]
20. The physiologic availability of phenylbutazone tablets marketed in India.
Manek SP; Tipnis HP; Kulkarni RD
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):163-7. PubMed ID: 7263103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
